PHILLIP MD ET AL FROST Insider Trading $EXEG OPKO HEALTH, INC.
Get free email notifications about insider trading for PHILLIP MD ET AL FROST.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of PHILLIP MD ET AL FROST. PHILLIP MD ET AL FROST is 10% Owner in VECTOR GROUP LTD ($VGR) and 10% Owner in NON INVASIVE MONITORING SYSTEMS INC /FL/ ($NIMU) and CEO & Chairman in Opko Health, Inc. ($EXEG) and 10% Owner in Tiger X Medical, Inc. ($CLIK) and in LADENBURG THALMANN FINANCIAL SERVICES INC. ($LTS) and 10% Owner in LADENBURG THALMANN FINANCIAL SERVICES INC. ($LTS) and Director in LADENBURG THALMANN FINANCIAL SERVICES INC ($LTS) and in Sevion Therapeutics, Inc. ($SVON) and Director in Sevion Therapeutics, Inc. ($SVON) and Director in Castle Brands Inc ($ROX) and in Cocrystal Pharma, Inc. ($BZNE) and Director in Cocrystal Pharma, Inc. ($COCP) and 10% Owner in IDI, Inc. ($IDI) and Director in IDI, Inc. ($IDI) and 10% Owner in Red Violet, Inc. ($RDVT).
PHILLIP MD ET AL FROST in OPKO HEALTH, INC.
Trading Symbol: EXEGIndustry: PHARMACEUTICAL PREPARATIONS [2834]
Position of PHILLIP MD ET AL FROST: CEO & Chairman
Holdings: 192,297,694 shares
Latest Transaction: May 11 2021
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of PHILLIP MD ET AL FROST in OPKO HEALTH, INC.
Sentiment: All, BCDA, ROX, COCP, ELOX, FLNT, LTS, NIMU, EXEG, RDVT, VGR
Page: < prev 1 ... 4 5 6 7 8 9 10 11 12 ... 30 next >
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Mar 28 2018 | EXEG | Opko Health, Inc. | FROST PHILLIP MD ET AL | CEO & Chairman | Buy | P | 3.22 | 5,000 | 16,100 | 2,386,800 | 2.4 M to 2.4 M (+0.21 %) |
Mar 28 2018 | EXEG | Opko Health, Inc. | FROST PHILLIP MD ET AL | CEO & Chairman | Buy | P | 3.21 | 1,200 | 3,852 | 2,381,800 | 2.4 M to 2.4 M (+0.05 %) |
Mar 28 2018 | EXEG | Opko Health, Inc. | FROST PHILLIP MD ET AL | CEO & Chairman | Buy | P | 3.21 | 300 | 962 | 2,380,600 | 2.4 M to 2.4 M (+0.01 %) |
Mar 28 2018 | EXEG | Opko Health, Inc. | FROST PHILLIP MD ET AL | CEO & Chairman | Buy | P | 3.21 | 3,500 | 11,218 | 2,380,300 | 2.4 M to 2.4 M (+0.15 %) |
Mar 28 2018 | EXEG | Opko Health, Inc. | FROST PHILLIP MD ET AL | CEO & Chairman | Buy | P | 3.20 | 2,000 | 6,400 | 2,376,800 | 2.4 M to 2.4 M (+0.08 %) |
Mar 28 2018 | EXEG | Opko Health, Inc. | FROST PHILLIP MD ET AL | CEO & Chairman | Buy | P | 3.20 | 3,000 | 9,585 | 2,374,800 | 2.4 M to 2.4 M (+0.13 %) |
Mar 28 2018 | EXEG | Opko Health, Inc. | FROST PHILLIP MD ET AL | CEO & Chairman | Buy | P | 3.18 | 7,500 | 23,850 | 2,371,800 | 2.4 M to 2.4 M (+0.32 %) |
Mar 28 2018 | EXEG | Opko Health, Inc. | FROST PHILLIP MD ET AL | CEO & Chairman | Buy | P | 3.18 | 500 | 1,589 | 2,364,300 | 2.4 M to 2.4 M (+0.02 %) |
Mar 28 2018 | EXEG | Opko Health, Inc. | FROST PHILLIP MD ET AL | CEO & Chairman | Buy | P | 3.18 | 2,000 | 6,350 | 2,363,800 | 2.4 M to 2.4 M (+0.08 %) |
Mar 27 2018 | EXEG | Opko Health, Inc. | FROST PHILLIP MD ET AL | CEO & Chairman | Buy | P | 3.25 | 2,800 | 9,100 | 2,361,800 | 2.4 M to 2.4 M (+0.12 %) |
Mar 27 2018 | EXEG | Opko Health, Inc. | FROST PHILLIP MD ET AL | CEO & Chairman | Buy | P | 3.25 | 900 | 2,923 | 2,359,000 | 2.4 M to 2.4 M (+0.04 %) |
Mar 27 2018 | EXEG | Opko Health, Inc. | FROST PHILLIP MD ET AL | CEO & Chairman | Buy | P | 3.25 | 1,300 | 4,219 | 2,358,100 | 2.4 M to 2.4 M (+0.06 %) |
Mar 27 2018 | EXEG | Opko Health, Inc. | FROST PHILLIP MD ET AL | CEO & Chairman | Buy | P | 3.22 | 5,000 | 16,100 | 2,356,800 | 2.4 M to 2.4 M (+0.21 %) |
Mar 27 2018 | EXEG | Opko Health, Inc. | FROST PHILLIP MD ET AL | CEO & Chairman | Buy | P | 3.18 | 1,900 | 6,042 | 2,351,800 | 2.3 M to 2.4 M (+0.08 %) |
Mar 27 2018 | EXEG | Opko Health, Inc. | FROST PHILLIP MD ET AL | CEO & Chairman | Buy | P | 3.18 | 4,100 | 13,018 | 2,349,900 | 2.3 M to 2.3 M (+0.17 %) |
Mar 27 2018 | EXEG | Opko Health, Inc. | FROST PHILLIP MD ET AL | CEO & Chairman | Buy | P | 3.17 | 5,264 | 16,687 | 2,345,800 | 2.3 M to 2.3 M (+0.22 %) |
Mar 27 2018 | EXEG | Opko Health, Inc. | FROST PHILLIP MD ET AL | CEO & Chairman | Buy | P | 3.17 | 200 | 634 | 2,340,536 | 2.3 M to 2.3 M (+0.01 %) |
Mar 27 2018 | EXEG | Opko Health, Inc. | FROST PHILLIP MD ET AL | CEO & Chairman | Buy | P | 3.17 | 100 | 317 | 2,340,336 | 2.3 M to 2.3 M (0.00 %) |
Mar 27 2018 | EXEG | Opko Health, Inc. | FROST PHILLIP MD ET AL | CEO & Chairman | Buy | P | 3.16 | 4,436 | 14,018 | 2,340,236 | 2.3 M to 2.3 M (+0.19 %) |
Mar 26 2018 | EXEG | Opko Health, Inc. | FROST PHILLIP MD ET AL | CEO & Chairman | Buy | P | 3.28 | 10,000 | 32,750 | 2,335,800 | 2.3 M to 2.3 M (+0.43 %) |
Mar 26 2018 | EXEG | Opko Health, Inc. | FROST PHILLIP MD ET AL | CEO & Chairman | Buy | P | 3.27 | 5,000 | 16,350 | 2,325,800 | 2.3 M to 2.3 M (+0.22 %) |
Mar 26 2018 | EXEG | Opko Health, Inc. | FROST PHILLIP MD ET AL | CEO & Chairman | Buy | P | 3.26 | 10,000 | 32,600 | 2,320,800 | 2.3 M to 2.3 M (+0.43 %) |
Mar 23 2018 | EXEG | Opko Health, Inc. | FROST PHILLIP MD ET AL | CEO & Chairman | Buy | P | 3.39 | 5,000 | 16,950 | 2,310,800 | 2.3 M to 2.3 M (+0.22 %) |
Mar 23 2018 | EXEG | Opko Health, Inc. | FROST PHILLIP MD ET AL | CEO & Chairman | Buy | P | 3.35 | 3,400 | 11,390 | 2,305,800 | 2.3 M to 2.3 M (+0.15 %) |
Mar 23 2018 | EXEG | Opko Health, Inc. | FROST PHILLIP MD ET AL | CEO & Chairman | Buy | P | 3.35 | 1,600 | 5,352 | 2,302,400 | 2.3 M to 2.3 M (+0.07 %) |
Mar 23 2018 | EXEG | Opko Health, Inc. | FROST PHILLIP MD ET AL | CEO & Chairman | Buy | P | 3.31 | 3,600 | 11,916 | 2,300,800 | 2.3 M to 2.3 M (+0.16 %) |
Mar 23 2018 | EXEG | Opko Health, Inc. | FROST PHILLIP MD ET AL | CEO & Chairman | Buy | P | 3.31 | 100 | 331 | 2,297,200 | 2.3 M to 2.3 M (0.00 %) |
Mar 23 2018 | EXEG | Opko Health, Inc. | FROST PHILLIP MD ET AL | CEO & Chairman | Buy | P | 3.31 | 1,300 | 4,297 | 2,297,100 | 2.3 M to 2.3 M (+0.06 %) |
Mar 23 2018 | EXEG | Opko Health, Inc. | FROST PHILLIP MD ET AL | CEO & Chairman | Buy | P | 3.30 | 100 | 330 | 2,295,800 | 2.3 M to 2.3 M (0.00 %) |
Mar 23 2018 | EXEG | Opko Health, Inc. | FROST PHILLIP MD ET AL | CEO & Chairman | Buy | P | 3.30 | 100 | 330 | 2,295,700 | 2.3 M to 2.3 M (0.00 %) |
Mar 23 2018 | EXEG | Opko Health, Inc. | FROST PHILLIP MD ET AL | CEO & Chairman | Buy | P | 3.29 | 4,600 | 15,134 | 2,295,600 | 2.3 M to 2.3 M (+0.20 %) |
Mar 23 2018 | EXEG | Opko Health, Inc. | FROST PHILLIP MD ET AL | CEO & Chairman | Buy | P | 3.29 | 200 | 657 | 2,291,000 | 2.3 M to 2.3 M (+0.01 %) |
Mar 23 2018 | EXEG | Opko Health, Inc. | FROST PHILLIP MD ET AL | CEO & Chairman | Buy | P | 3.28 | 8,712 | 28,575 | 2,290,800 | 2.3 M to 2.3 M (+0.38 %) |
Mar 23 2018 | EXEG | Opko Health, Inc. | FROST PHILLIP MD ET AL | CEO & Chairman | Buy | P | 3.28 | 200 | 656 | 2,282,088 | 2.3 M to 2.3 M (+0.01 %) |
Mar 23 2018 | EXEG | Opko Health, Inc. | FROST PHILLIP MD ET AL | CEO & Chairman | Buy | P | 3.28 | 1,088 | 3,563 | 2,281,888 | 2.3 M to 2.3 M (+0.05 %) |
Mar 22 2018 | EXEG | Opko Health, Inc. | FROST PHILLIP MD ET AL | CEO & Chairman | Buy | P | 3.39 | 9,700 | 32,883 | 2,280,800 | 2.3 M to 2.3 M (+0.43 %) |
Mar 22 2018 | EXEG | Opko Health, Inc. | FROST PHILLIP MD ET AL | CEO & Chairman | Buy | P | 3.39 | 300 | 1,016 | 2,271,100 | 2.3 M to 2.3 M (+0.01 %) |
Mar 22 2018 | EXEG | Opko Health, Inc. | FROST PHILLIP MD ET AL | CEO & Chairman | Buy | P | 3.38 | 8,250 | 27,885 | 2,270,800 | 2.3 M to 2.3 M (+0.36 %) |
Mar 22 2018 | EXEG | Opko Health, Inc. | FROST PHILLIP MD ET AL | CEO & Chairman | Buy | P | 3.38 | 400 | 1,351 | 2,262,550 | 2.3 M to 2.3 M (+0.02 %) |
Mar 22 2018 | EXEG | Opko Health, Inc. | FROST PHILLIP MD ET AL | CEO & Chairman | Buy | P | 3.38 | 1,350 | 4,556 | 2,262,150 | 2.3 M to 2.3 M (+0.06 %) |
Mar 22 2018 | EXEG | Opko Health, Inc. | FROST PHILLIP MD ET AL | CEO & Chairman | Buy | P | 3.37 | 8,100 | 27,297 | 2,260,800 | 2.3 M to 2.3 M (+0.36 %) |
Mar 22 2018 | EXEG | Opko Health, Inc. | FROST PHILLIP MD ET AL | CEO & Chairman | Buy | P | 3.37 | 1,000 | 3,368 | 2,252,700 | 2.3 M to 2.3 M (+0.04 %) |
Mar 22 2018 | EXEG | Opko Health, Inc. | FROST PHILLIP MD ET AL | CEO & Chairman | Buy | P | 3.37 | 900 | 3,029 | 2,251,700 | 2.3 M to 2.3 M (+0.04 %) |
Mar 21 2018 | EXEG | Opko Health, Inc. | FROST PHILLIP MD ET AL | CEO & Chairman | Buy | P | 3.45 | 3,706 | 12,786 | 2,250,800 | 2.2 M to 2.3 M (+0.16 %) |
Mar 21 2018 | EXEG | Opko Health, Inc. | FROST PHILLIP MD ET AL | CEO & Chairman | Buy | P | 3.45 | 300 | 1,034 | 2,247,094 | 2.2 M to 2.2 M (+0.01 %) |
Mar 21 2018 | EXEG | Opko Health, Inc. | FROST PHILLIP MD ET AL | CEO & Chairman | Buy | P | 3.45 | 994 | 3,424 | 2,246,794 | 2.2 M to 2.2 M (+0.04 %) |
Mar 21 2018 | EXEG | Opko Health, Inc. | FROST PHILLIP MD ET AL | CEO & Chairman | Buy | P | 3.40 | 5,000 | 17,000 | 2,245,800 | 2.2 M to 2.2 M (+0.22 %) |
Mar 21 2018 | EXEG | Opko Health, Inc. | FROST PHILLIP MD ET AL | CEO & Chairman | Buy | P | 3.37 | 2,500 | 8,425 | 2,240,800 | 2.2 M to 2.2 M (+0.11 %) |
Mar 21 2018 | EXEG | Opko Health, Inc. | FROST PHILLIP MD ET AL | CEO & Chairman | Buy | P | 3.35 | 9,800 | 32,830 | 2,238,300 | 2.2 M to 2.2 M (+0.44 %) |
Mar 21 2018 | EXEG | Opko Health, Inc. | FROST PHILLIP MD ET AL | CEO & Chairman | Buy | P | 3.35 | 200 | 669 | 2,228,500 | 2.2 M to 2.2 M (+0.01 %) |
Mar 21 2018 | EXEG | Opko Health, Inc. | FROST PHILLIP MD ET AL | CEO & Chairman | Buy | P | 3.32 | 8,700 | 28,884 | 2,228,300 | 2.2 M to 2.2 M (+0.39 %) |
Mar 21 2018 | EXEG | Opko Health, Inc. | FROST PHILLIP MD ET AL | CEO & Chairman | Buy | P | 3.32 | 600 | 1,991 | 2,219,600 | 2.2 M to 2.2 M (+0.03 %) |
Mar 21 2018 | EXEG | Opko Health, Inc. | FROST PHILLIP MD ET AL | CEO & Chairman | Buy | P | 3.32 | 2,900 | 9,614 | 2,219,000 | 2.2 M to 2.2 M (+0.13 %) |
Mar 21 2018 | EXEG | Opko Health, Inc. | FROST PHILLIP MD ET AL | CEO & Chairman | Buy | P | 3.31 | 17,700 | 58,587 | 2,216,100 | 2.2 M to 2.2 M (+0.81 %) |
Mar 21 2018 | EXEG | Opko Health, Inc. | FROST PHILLIP MD ET AL | CEO & Chairman | Buy | P | 3.31 | 100 | 331 | 2,198,400 | 2.2 M to 2.2 M (0.00 %) |
Mar 21 2018 | EXEG | Opko Health, Inc. | FROST PHILLIP MD ET AL | CEO & Chairman | Buy | P | 3.29 | 9,800 | 32,242 | 2,198,300 | 2.2 M to 2.2 M (+0.45 %) |
Mar 21 2018 | EXEG | Opko Health, Inc. | FROST PHILLIP MD ET AL | CEO & Chairman | Buy | P | 3.29 | 200 | 657 | 2,188,500 | 2.2 M to 2.2 M (+0.01 %) |
Mar 21 2018 | EXEG | Opko Health, Inc. | FROST PHILLIP MD ET AL | CEO & Chairman | Buy | P | 3.28 | 2,500 | 8,200 | 2,188,300 | 2.2 M to 2.2 M (+0.11 %) |
Mar 21 2018 | EXEG | Opko Health, Inc. | FROST PHILLIP MD ET AL | CEO & Chairman | Buy | P | 3.27 | 8,100 | 26,487 | 2,185,800 | 2.2 M to 2.2 M (+0.37 %) |
Mar 21 2018 | EXEG | Opko Health, Inc. | FROST PHILLIP MD ET AL | CEO & Chairman | Buy | P | 3.27 | 500 | 1,634 | 2,177,700 | 2.2 M to 2.2 M (+0.02 %) |
Mar 21 2018 | EXEG | Opko Health, Inc. | FROST PHILLIP MD ET AL | CEO & Chairman | Buy | P | 3.27 | 1,400 | 4,571 | 2,177,200 | 2.2 M to 2.2 M (+0.06 %) |
Mar 20 2018 | EXEG | Opko Health, Inc. | FROST PHILLIP MD ET AL | CEO & Chairman | Buy | P | 3.54 | 9,000 | 31,860 | 2,175,800 | 2.2 M to 2.2 M (+0.42 %) |
Mar 20 2018 | EXEG | Opko Health, Inc. | FROST PHILLIP MD ET AL | CEO & Chairman | Buy | P | 3.54 | 4,000 | 14,140 | 2,166,800 | 2.2 M to 2.2 M (+0.18 %) |
Mar 20 2018 | EXEG | Opko Health, Inc. | FROST PHILLIP MD ET AL | CEO & Chairman | Buy | P | 3.53 | 4,000 | 14,120 | 2,162,800 | 2.2 M to 2.2 M (+0.19 %) |
Mar 20 2018 | EXEG | Opko Health, Inc. | FROST PHILLIP MD ET AL | CEO & Chairman | Buy | P | 3.52 | 3,300 | 11,616 | 2,158,800 | 2.2 M to 2.2 M (+0.15 %) |
Mar 20 2018 | EXEG | Opko Health, Inc. | FROST PHILLIP MD ET AL | CEO & Chairman | Buy | P | 3.52 | 100 | 352 | 2,155,500 | 2.2 M to 2.2 M (0.00 %) |
Mar 20 2018 | EXEG | Opko Health, Inc. | FROST PHILLIP MD ET AL | CEO & Chairman | Buy | P | 3.52 | 1,600 | 5,624 | 2,155,400 | 2.2 M to 2.2 M (+0.07 %) |
Mar 20 2018 | EXEG | Opko Health, Inc. | FROST PHILLIP MD ET AL | CEO & Chairman | Buy | P | 3.50 | 2,000 | 7,000 | 2,153,800 | 2.2 M to 2.2 M (+0.09 %) |
Mar 20 2018 | EXEG | Opko Health, Inc. | FROST PHILLIP MD ET AL | CEO & Chairman | Buy | P | 3.49 | 4,800 | 16,752 | 2,151,800 | 2.1 M to 2.2 M (+0.22 %) |
Mar 20 2018 | EXEG | Opko Health, Inc. | FROST PHILLIP MD ET AL | CEO & Chairman | Buy | P | 3.49 | 200 | 697 | 2,147,000 | 2.1 M to 2.1 M (+0.01 %) |
Mar 20 2018 | EXEG | Opko Health, Inc. | FROST PHILLIP MD ET AL | CEO & Chairman | Buy | P | 3.47 | 2,000 | 6,940 | 2,146,800 | 2.1 M to 2.1 M (+0.09 %) |
Mar 20 2018 | EXEG | Opko Health, Inc. | FROST PHILLIP MD ET AL | CEO & Chairman | Buy | P | 3.46 | 8,900 | 30,794 | 2,144,800 | 2.1 M to 2.1 M (+0.42 %) |
Mar 20 2018 | EXEG | Opko Health, Inc. | FROST PHILLIP MD ET AL | CEO & Chairman | Buy | P | 3.46 | 100 | 346 | 2,135,900 | 2.1 M to 2.1 M (0.00 %) |
Mar 16 2018 | EXEG | Opko Health, Inc. | FROST PHILLIP MD ET AL | CEO & Chairman | Buy | P | 3.38 | 6,579 | 22,237 | 2,135,800 | 2.1 M to 2.1 M (+0.31 %) |
Mar 16 2018 | EXEG | Opko Health, Inc. | FROST PHILLIP MD ET AL | CEO & Chairman | Buy | P | 3.38 | 600 | 2,027 | 2,129,221 | 2.1 M to 2.1 M (+0.03 %) |
Mar 16 2018 | EXEG | Opko Health, Inc. | FROST PHILLIP MD ET AL | CEO & Chairman | Buy | P | 3.38 | 2,821 | 9,521 | 2,128,621 | 2.1 M to 2.1 M (+0.13 %) |
Mar 16 2018 | EXEG | Opko Health, Inc. | FROST PHILLIP MD ET AL | CEO & Chairman | Buy | P | 3.36 | 2,600 | 8,736 | 2,125,800 | 2.1 M to 2.1 M (+0.12 %) |
Mar 16 2018 | EXEG | Opko Health, Inc. | FROST PHILLIP MD ET AL | CEO & Chairman | Buy | P | 3.36 | 100 | 336 | 2,123,200 | 2.1 M to 2.1 M (0.00 %) |
Mar 16 2018 | EXEG | Opko Health, Inc. | FROST PHILLIP MD ET AL | CEO & Chairman | Buy | P | 3.36 | 3,300 | 11,072 | 2,123,100 | 2.1 M to 2.1 M (+0.16 %) |
Mar 16 2018 | EXEG | Opko Health, Inc. | FROST PHILLIP MD ET AL | CEO & Chairman | Buy | P | 3.35 | 2,101 | 7,038 | 2,119,800 | 2.1 M to 2.1 M (+0.10 %) |
Mar 16 2018 | EXEG | Opko Health, Inc. | FROST PHILLIP MD ET AL | CEO & Chairman | Buy | P | 3.35 | 200 | 670 | 2,117,699 | 2.1 M to 2.1 M (+0.01 %) |
Mar 16 2018 | EXEG | Opko Health, Inc. | FROST PHILLIP MD ET AL | CEO & Chairman | Buy | P | 3.35 | 2,699 | 9,028 | 2,117,499 | 2.1 M to 2.1 M (+0.13 %) |
Mar 16 2018 | EXEG | Opko Health, Inc. | FROST PHILLIP MD ET AL | CEO & Chairman | Buy | P | 3.34 | 7,000 | 23,380 | 2,114,800 | 2.1 M to 2.1 M (+0.33 %) |
Mar 16 2018 | EXEG | Opko Health, Inc. | FROST PHILLIP MD ET AL | CEO & Chairman | Buy | P | 3.34 | 600 | 2,003 | 2,107,800 | 2.1 M to 2.1 M (+0.03 %) |
Mar 16 2018 | EXEG | Opko Health, Inc. | FROST PHILLIP MD ET AL | CEO & Chairman | Buy | P | 3.34 | 2,400 | 8,004 | 2,107,200 | 2.1 M to 2.1 M (+0.11 %) |
Mar 16 2018 | EXEG | Opko Health, Inc. | FROST PHILLIP MD ET AL | CEO & Chairman | Buy | P | 3.30 | 5,000 | 16,500 | 2,104,800 | 2.1 M to 2.1 M (+0.24 %) |
Mar 16 2018 | EXEG | Opko Health, Inc. | FROST PHILLIP MD ET AL | CEO & Chairman | Buy | P | 3.29 | 3,400 | 11,186 | 2,099,800 | 2.1 M to 2.1 M (+0.16 %) |
Mar 16 2018 | EXEG | Opko Health, Inc. | FROST PHILLIP MD ET AL | CEO & Chairman | Buy | P | 3.29 | 300 | 986 | 2,096,400 | 2.1 M to 2.1 M (+0.01 %) |
Mar 16 2018 | EXEG | Opko Health, Inc. | FROST PHILLIP MD ET AL | CEO & Chairman | Buy | P | 3.29 | 1,300 | 4,271 | 2,096,100 | 2.1 M to 2.1 M (+0.06 %) |
Mar 16 2018 | EXEG | Opko Health, Inc. | FROST PHILLIP MD ET AL | CEO & Chairman | Buy | P | 3.28 | 9,962 | 32,675 | 2,094,800 | 2.1 M to 2.1 M (+0.48 %) |
Mar 16 2018 | EXEG | Opko Health, Inc. | FROST PHILLIP MD ET AL | CEO & Chairman | Buy | P | 3.28 | 500 | 1,639 | 2,084,838 | 2.1 M to 2.1 M (+0.02 %) |
Mar 16 2018 | EXEG | Opko Health, Inc. | FROST PHILLIP MD ET AL | CEO & Chairman | Buy | P | 3.28 | 5,500 | 18,013 | 2,084,338 | 2.1 M to 2.1 M (+0.26 %) |
Mar 16 2018 | EXEG | Opko Health, Inc. | FROST PHILLIP MD ET AL | CEO & Chairman | Buy | P | 3.27 | 4,038 | 13,204 | 2,078,838 | 2.1 M to 2.1 M (+0.19 %) |
Mar 14 2018 | EXEG | Opko Health, Inc. | FROST PHILLIP MD ET AL | CEO & Chairman | Buy | P | 3.42 | 6,000 | 20,490 | 2,074,800 | 2.1 M to 2.1 M (+0.29 %) |
Mar 14 2018 | EXEG | Opko Health, Inc. | FROST PHILLIP MD ET AL | CEO & Chairman | Buy | P | 3.41 | 3,000 | 10,230 | 2,068,800 | 2.1 M to 2.1 M (+0.15 %) |
Mar 14 2018 | EXEG | Opko Health, Inc. | FROST PHILLIP MD ET AL | CEO & Chairman | Buy | P | 3.41 | 1,000 | 3,405 | 2,065,800 | 2.1 M to 2.1 M (+0.05 %) |
Mar 14 2018 | EXEG | Opko Health, Inc. | FROST PHILLIP MD ET AL | CEO & Chairman | Buy | P | 3.38 | 100 | 338 | 2,064,800 | 2.1 M to 2.1 M (0.00 %) |
Mar 14 2018 | EXEG | Opko Health, Inc. | FROST PHILLIP MD ET AL | CEO & Chairman | Buy | P | 3.37 | 8,400 | 28,308 | 2,064,700 | 2.1 M to 2.1 M (+0.41 %) |
Mar 14 2018 | EXEG | Opko Health, Inc. | FROST PHILLIP MD ET AL | CEO & Chairman | Buy | P | 3.37 | 1,600 | 5,384 | 2,056,300 | 2.1 M to 2.1 M (+0.08 %) |
Mar 14 2018 | EXEG | Opko Health, Inc. | FROST PHILLIP MD ET AL | CEO & Chairman | Buy | P | 3.36 | 24,250 | 81,480 | 2,054,700 | 2 M to 2.1 M (+1.19 %) |
Mar 14 2018 | EXEG | Opko Health, Inc. | FROST PHILLIP MD ET AL | CEO & Chairman | Buy | P | 3.36 | 300 | 1,007 | 2,030,450 | 2 M to 2 M (+0.01 %) |
Mar 14 2018 | EXEG | Opko Health, Inc. | FROST PHILLIP MD ET AL | CEO & Chairman | Buy | P | 3.36 | 2,850 | 9,562 | 2,030,150 | 2 M to 2 M (+0.14 %) |
Mar 14 2018 | EXEG | Opko Health, Inc. | FROST PHILLIP MD ET AL | CEO & Chairman | Buy | P | 3.35 | 679 | 2,275 | 2,027,300 | 2 M to 2 M (+0.03 %) |
Mar 14 2018 | EXEG | Opko Health, Inc. | FROST PHILLIP MD ET AL | CEO & Chairman | Buy | P | 3.34 | 18,321 | 61,192 | 2,026,621 | 2 M to 2 M (+0.91 %) |
Mar 14 2018 | EXEG | Opko Health, Inc. | FROST PHILLIP MD ET AL | CEO & Chairman | Buy | P | 3.34 | 300 | 1,001 | 2,008,300 | 2 M to 2 M (+0.01 %) |
Mar 14 2018 | EXEG | Opko Health, Inc. | FROST PHILLIP MD ET AL | CEO & Chairman | Buy | P | 3.34 | 700 | 2,335 | 2,008,000 | 2 M to 2 M (+0.03 %) |
Mar 13 2018 | EXEG | Opko Health, Inc. | FROST PHILLIP MD ET AL | CEO & Chairman | Buy | P | 3.53 | 5,000 | 17,650 | 2,007,300 | 2 M to 2 M (+0.25 %) |
Mar 13 2018 | EXEG | Opko Health, Inc. | FROST PHILLIP MD ET AL | CEO & Chairman | Buy | P | 3.50 | 4,200 | 14,700 | 2,002,300 | 2 M to 2 M (+0.21 %) |
Mar 13 2018 | EXEG | Opko Health, Inc. | FROST PHILLIP MD ET AL | CEO & Chairman | Buy | P | 3.50 | 800 | 2,796 | 1,998,100 | 2 M to 2 M (+0.04 %) |
Mar 13 2018 | EXEG | Opko Health, Inc. | FROST PHILLIP MD ET AL | CEO & Chairman | Buy | P | 3.49 | 5,000 | 17,450 | 1,997,300 | 2 M to 2 M (+0.25 %) |
Mar 13 2018 | EXEG | Opko Health, Inc. | FROST PHILLIP MD ET AL | CEO & Chairman | Buy | P | 3.46 | 4,800 | 16,608 | 1,992,300 | 2 M to 2 M (+0.24 %) |
Mar 13 2018 | EXEG | Opko Health, Inc. | FROST PHILLIP MD ET AL | CEO & Chairman | Buy | P | 3.46 | 200 | 691 | 1,987,500 | 2 M to 2 M (+0.01 %) |
Mar 13 2018 | EXEG | Opko Health, Inc. | FROST PHILLIP MD ET AL | CEO & Chairman | Buy | P | 3.42 | 5,000 | 17,100 | 1,987,300 | 2 M to 2 M (+0.25 %) |
Mar 09 2018 | EXEG | Opko Health, Inc. | FROST PHILLIP MD ET AL | CEO & Chairman | Buy | P | 3.34 | 5,000 | 16,700 | 1,982,300 | 2 M to 2 M (+0.25 %) |
Mar 09 2018 | EXEG | Opko Health, Inc. | FROST PHILLIP MD ET AL | CEO & Chairman | Buy | P | 3.32 | 3,550 | 11,786 | 1,977,300 | 2 M to 2 M (+0.18 %) |
Mar 09 2018 | EXEG | Opko Health, Inc. | FROST PHILLIP MD ET AL | CEO & Chairman | Buy | P | 3.34 | 5,000 | 16,700 | 1,982,300 | 2 M to 2 M (+0.25 %) |
Mar 09 2018 | EXEG | Opko Health, Inc. | FROST PHILLIP MD ET AL | CEO & Chairman | Buy | P | 3.32 | 1,450 | 4,807 | 1,973,750 | 2 M to 2 M (+0.07 %) |
Mar 09 2018 | EXEG | Opko Health, Inc. | FROST PHILLIP MD ET AL | CEO & Chairman | Buy | P | 3.32 | 3,550 | 11,786 | 1,977,300 | 2 M to 2 M (+0.18 %) |
Mar 09 2018 | EXEG | Opko Health, Inc. | FROST PHILLIP MD ET AL | CEO & Chairman | Buy | P | 3.26 | 5,000 | 16,300 | 1,972,300 | 2 M to 2 M (+0.25 %) |
Mar 09 2018 | EXEG | Opko Health, Inc. | FROST PHILLIP MD ET AL | CEO & Chairman | Buy | P | 3.32 | 1,450 | 4,807 | 1,973,750 | 2 M to 2 M (+0.07 %) |
Mar 09 2018 | EXEG | Opko Health, Inc. | FROST PHILLIP MD ET AL | CEO & Chairman | Buy | P | 3.25 | 15,500 | 50,375 | 1,967,300 | 2 M to 2 M (+0.79 %) |
Mar 09 2018 | EXEG | Opko Health, Inc. | FROST PHILLIP MD ET AL | CEO & Chairman | Buy | P | 3.26 | 5,000 | 16,300 | 1,972,300 | 2 M to 2 M (+0.25 %) |
Mar 09 2018 | EXEG | Opko Health, Inc. | FROST PHILLIP MD ET AL | CEO & Chairman | Buy | P | 3.25 | 1,500 | 4,868 | 1,951,800 | 2 M to 2 M (+0.08 %) |
Mar 09 2018 | EXEG | Opko Health, Inc. | FROST PHILLIP MD ET AL | CEO & Chairman | Buy | P | 3.25 | 15,500 | 50,375 | 1,967,300 | 2 M to 2 M (+0.79 %) |
Mar 09 2018 | EXEG | Opko Health, Inc. | FROST PHILLIP MD ET AL | CEO & Chairman | Buy | P | 3.25 | 1,500 | 4,868 | 1,951,800 | 2 M to 2 M (+0.08 %) |
Mar 08 2018 | EXEG | Opko Health, Inc. | FROST PHILLIP MD ET AL | CEO & Chairman | Buy | P | 3.37 | 4,700 | 15,839 | 1,950,300 | 1.9 M to 2 M (+0.24 %) |
Mar 08 2018 | EXEG | Opko Health, Inc. | FROST PHILLIP MD ET AL | CEO & Chairman | Buy | P | 3.37 | 100 | 337 | 1,945,600 | 1.9 M to 1.9 M (+0.01 %) |
Mar 08 2018 | EXEG | Opko Health, Inc. | FROST PHILLIP MD ET AL | CEO & Chairman | Buy | P | 3.37 | 200 | 673 | 1,945,500 | 1.9 M to 1.9 M (+0.01 %) |
Mar 08 2018 | EXEG | Opko Health, Inc. | FROST PHILLIP MD ET AL | CEO & Chairman | Buy | P | 3.35 | 5,000 | 16,750 | 1,945,300 | 1.9 M to 1.9 M (+0.26 %) |
Mar 08 2018 | EXEG | Opko Health, Inc. | FROST PHILLIP MD ET AL | CEO & Chairman | Buy | P | 3.34 | 5,900 | 19,706 | 1,940,300 | 1.9 M to 1.9 M (+0.31 %) |
Mar 08 2018 | EXEG | Opko Health, Inc. | FROST PHILLIP MD ET AL | CEO & Chairman | Buy | P | 3.34 | 500 | 1,669 | 1,934,400 | 1.9 M to 1.9 M (+0.03 %) |
Mar 08 2018 | EXEG | Opko Health, Inc. | FROST PHILLIP MD ET AL | CEO & Chairman | Buy | P | 3.34 | 3,600 | 12,006 | 1,933,900 | 1.9 M to 1.9 M (+0.19 %) |
Mar 08 2018 | EXEG | Opko Health, Inc. | FROST PHILLIP MD ET AL | CEO & Chairman | Buy | P | 3.33 | 10,000 | 33,300 | 1,930,300 | 1.9 M to 1.9 M (+0.52 %) |
Mar 08 2018 | EXEG | Opko Health, Inc. | FROST PHILLIP MD ET AL | CEO & Chairman | Buy | P | 3.30 | 15,000 | 49,500 | 1,920,300 | 1.9 M to 1.9 M (+0.79 %) |
Mar 08 2018 | EXEG | Opko Health, Inc. | FROST PHILLIP MD ET AL | CEO & Chairman | Buy | P | 3.27 | 3,900 | 12,753 | 1,905,300 | 1.9 M to 1.9 M (+0.21 %) |
Mar 08 2018 | EXEG | Opko Health, Inc. | FROST PHILLIP MD ET AL | CEO & Chairman | Buy | P | 3.27 | 100 | 327 | 1,901,400 | 1.9 M to 1.9 M (+0.01 %) |
Mar 08 2018 | EXEG | Opko Health, Inc. | FROST PHILLIP MD ET AL | CEO & Chairman | Buy | P | 3.27 | 1,000 | 3,265 | 1,901,300 | 1.9 M to 1.9 M (+0.05 %) |
Mar 08 2018 | EXEG | Opko Health, Inc. | FROST PHILLIP MD ET AL | CEO & Chairman | Buy | P | 3.26 | 5,000 | 16,300 | 1,900,300 | 1.9 M to 1.9 M (+0.26 %) |
Mar 08 2018 | EXEG | Opko Health, Inc. | FROST PHILLIP MD ET AL | CEO & Chairman | Buy | P | 3.24 | 48 | 156 | 1,895,300 | 1.9 M to 1.9 M (0.00 %) |
Mar 08 2018 | EXEG | Opko Health, Inc. | FROST PHILLIP MD ET AL | CEO & Chairman | Buy | P | 3.24 | 4,952 | 16,020 | 1,895,252 | 1.9 M to 1.9 M (+0.26 %) |
Mar 08 2018 | EXEG | Opko Health, Inc. | FROST PHILLIP MD ET AL | CEO & Chairman | Buy | P | 3.23 | 5,000 | 16,150 | 1,890,300 | 1.9 M to 1.9 M (+0.27 %) |
Mar 08 2018 | EXEG | Opko Health, Inc. | FROST PHILLIP MD ET AL | CEO & Chairman | Buy | P | 3.22 | 9,300 | 29,946 | 1,885,300 | 1.9 M to 1.9 M (+0.50 %) |
Mar 08 2018 | EXEG | Opko Health, Inc. | FROST PHILLIP MD ET AL | CEO & Chairman | Buy | P | 3.22 | 200 | 644 | 1,876,000 | 1.9 M to 1.9 M (+0.01 %) |
Mar 08 2018 | EXEG | Opko Health, Inc. | FROST PHILLIP MD ET AL | CEO & Chairman | Buy | P | 3.22 | 500 | 1,608 | 1,875,800 | 1.9 M to 1.9 M (+0.03 %) |
Mar 05 2018 | EXEG | Opko Health, Inc. | FROST PHILLIP MD ET AL | CEO & Chairman | Buy | P | 2.94 | 364,800 | 1,073,716 | 1,875,300 | 1.5 M to 1.9 M (+24.15 %) |
Feb 22 2018 | EXEG | Opko Health, Inc. | FROST PHILLIP MD ET AL | CEO & Chairman | Buy | P | 3.69 | 9,100 | 33,579 | 1,510,500 | 1.5 M to 1.5 M (+0.61 %) |
Feb 22 2018 | EXEG | Opko Health, Inc. | FROST PHILLIP MD ET AL | CEO & Chairman | Buy | P | 3.69 | 6,900 | 25,427 | 1,501,400 | 1.5 M to 1.5 M (+0.46 %) |
Feb 22 2018 | EXEG | Opko Health, Inc. | FROST PHILLIP MD ET AL | CEO & Chairman | Buy | P | 3.67 | 15,800 | 57,986 | 1,494,500 | 1.5 M to 1.5 M (+1.07 %) |
Feb 22 2018 | EXEG | Opko Health, Inc. | FROST PHILLIP MD ET AL | CEO & Chairman | Buy | P | 3.66 | 6,200 | 22,692 | 1,478,700 | 1.5 M to 1.5 M (+0.42 %) |
Feb 22 2018 | EXEG | Opko Health, Inc. | FROST PHILLIP MD ET AL | CEO & Chairman | Buy | P | 3.65 | 25,400 | 92,710 | 1,472,500 | 1.4 M to 1.5 M (+1.76 %) |